Oliveira Francisco P M, Castelo-Branco Miguel
Institute for Nuclear Sciences Applied to Health (ICNAS-P), and Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Portugal.
J Neural Eng. 2015 Apr;12(2):026008. doi: 10.1088/1741-2560/12/2/026008. Epub 2015 Feb 24.
The aim of the present study was to develop a fully-automated computational solution for computer-aided diagnosis in Parkinson syndrome based on [(123)I]FP-CIT single photon emission computed tomography (SPECT) images.
A dataset of 654 [(123)I]FP-CIT SPECT brain images from the Parkinson's Progression Markers Initiative were used. Of these, 445 images were of patients with Parkinson's disease at an early stage and the remainder formed a control group. The images were pre-processed using automated template-based registration followed by the computation of the binding potential at a voxel level. Then, the binding potential images were used for classification, based on the voxel-as-feature approach and using the support vector machines paradigm.
The obtained estimated classification accuracy was 97.86%, the sensitivity was 97.75% and the specificity 98.09%.
The achieved classification accuracy was very high and, in fact, higher than accuracies found in previous studies reported in the literature. In addition, results were obtained on a large dataset of early Parkinson's disease subjects. In summation, the information provided by the developed computational solution potentially supports clinical decision-making in nuclear medicine, using important additional information beyond the commonly used uptake ratios and respective statistical comparisons. (ClinicalTrials.gov Identifier: NCT01141023).
本研究的目的是基于[(123)I] FP - CIT单光子发射计算机断层扫描(SPECT)图像开发一种用于帕金森综合征计算机辅助诊断的全自动计算解决方案。
使用了帕金森病进展标志物倡议项目中的654幅[(123)I] FP - CIT SPECT脑图像数据集。其中,445幅图像来自早期帕金森病患者,其余构成对照组。图像首先使用基于模板的自动配准进行预处理,然后在体素水平计算结合潜能。接着,基于体素特征方法并使用支持向量机范式,将结合潜能图像用于分类。
获得的估计分类准确率为97.86%,灵敏度为97.75%,特异性为98.09%。
所达到的分类准确率非常高,实际上高于文献中先前报道的研究中的准确率。此外,是在大量早期帕金森病受试者数据集上获得的结果。总之,所开发的计算解决方案提供的信息有可能支持核医学中的临床决策,利用了超出常用摄取率和各自统计比较的重要附加信息。(ClinicalTrials.gov标识符:NCT01141023)